U.S. Telehealth and Retail Lab Testing Market Size By Sample Type (Blood, Urine, Saliva), By Test Type (Routine Testing, Blood Cell Count, Cholesterol Level Testing), By End User (Diagnostics Laboratory, Hospital), By Mode of Payment (Insurance Pay, Consumer Pay), And Forecast

U.S. Telehealth and Retail Lab Testing Market Size And Forecast

U.S. Telehealth and Retail Lab Testing Market size was valued at USD 927.11 Million in 2021 and is projected to reach USD 3,120.99 Million by 2030, growing at a CAGR of 15.28% from 2023 to 2030.

The direct-to-consumer testing is a remarkable extension of the traditional healthcare model for consumers desiring information regarding their disease risk and health situation, ancestry, and their body’s probable response to certain prescriptions depending on their genotype. The benefits of direct-to-consumer testing are driving and enticing the telehealth and retail lab testing market. The U.S. Telehealth and Retail Lab Testing Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

What is Telehealth and Retail Lab Testing?

Using digital communication and information technologies to manage and access health care services distantly, telehealth is often an umbrella term including all components of health care achieved through technology, including wearable devices. It is portion of a tightly coordinated care network which meets patient healthcare needs in personalized, timely, and creative ways. When done correctly, telehealth supplements conventional care and allows a more holistic experience that knowingly combines in-person and digital visits.

The direct-to-consumer testing is a remarkable extension to the traditional healthcare model for consumers desiring information regarding their disease risk and health situation, ancestry, and their body’s probable response to certain prescriptions depending on their genotype. The benefits of direct-to-consumer testing are driving and enticing the telehealth and retail lab testing market.

U.S. Telehealth and Retail Lab Testing Market Overview

An exciting development in the healthcare industry is direct-to-consumer (DTC) testing, which gives patients access to comprehensive diagnostic reports about their health, ancestry, disease risk, and the body’s anticipated response to specific prescriptions based on their genotype. This new methodology is driving the development of the telehealth and retail lab testing market in the US, as shoppers are searching for more helpful and customized medical care choices.

In healthcare, patients must schedule an appointment for traditional laboratory testing and then wait for their test results and interpretive data. This cycle can be distressing and tedious, so no big surprise individuals are looking for another medical care model that is more helpful and gives more point by point symptomatic reports.

Telemedicine and virtual treatment have grown by leaps and bounds in recent years. This trend has fuelled the development of telehealth and research facility testing in the United States, as well as made medical treatment more accessible to a huge number of people worldwide.Previously, traditional clinical consideration models anticipated that the majority of tasks, such as laboratory tests, would necessitate patients visiting a specialist’s office or a crisis centre. This frequently meant long waits, heightened strain, and large financial outlays. Patients, on the other hand, now have access to healthcare services at their leisure and on their terms, thanks to advances in telemedicine and virtual care.

The way we approach healthcare has been fundamentally altered by direct-to-consumer (DTC) testing. Customers now have access to medical data about their health, disease risk, ancestry, and even how their body will react to certain medications based on their genotype. The rapid expansion of the DTC testing market, which is also driving the telehealth and retail lab testing markets, is clear.

While the advantages of DTC testing are various, it’s flawed. One of the biggest issues with DTC testing is that customers might get results that contain medical information they don’t understand, which could cause test results to be misinterpreted. Generally, the medical services supplier had the option to separate this data and make sense of it in a more edible manner. Nonetheless, DTC testing frequently gives buyers crude outcomes that can be hard to decipher. This can prompt a lot of nervousness and disarray.

It is becoming increasingly evident that the COVID-19 pandemic has had a significant impact on various industries as it continues to affect the world. Telehealth, retail, and lab testing are just a few of the areas of the healthcare industry that have experienced significant growth and change.

Since the beginning of the pandemic, more and more people are looking for ways to consult with healthcare professionals from a distance through telehealth. The number of providers offering virtual visits and teleconsultations as well as the number of virtual visits has increased as a result of this. Business pioneers can benefit from this pattern by extending their administrations to fulfil the developing need, joining forces with telehealth organizations, or fostering their own telehealth stages.

U.S. Telehealth and Retail Lab Testing MarketSegmentation Analysis

The U.S. Telehealth and Retail Lab Testing Market is segmented on the basis of Sample Type, Test Type, End user, And Mode of Payment.

U.S. Telehealth and Retail Lab Testing Market, By Sample Type

• Blood
• Urine
• Saliva
• Others

To Get a Summarized Market Report By Sample Type-

Based on Sample Type, the market is bifurcated into Blood, Urine, Saliva, and Others. Blood accounted for the largest market share of 40.61% in 2022, with a market value of USD 418.30 Million and is projected to grow at the highest CAGR of 17.63% during the forecast period. Urine was the second-largest market in 2022, valued at USD 290.12 Million in 2022; it is projected to grow at a CAGR of 15.84%.

U.S. Telehealth and Retail Lab Testing Market, By Test Type

• Routine Testing
• Blood Cell Count
• Cholesterol Level Testing
• Diabetes Testing
• HIV Testing
• Pregnancy Testing
• Others

To Get a Summarized Market Report By Test Type-

On the basis of Test Type, the U.S. Telehealth and Retail Lab Testing Market has been segmented into Routine Testing, Blood Cell Count, Cholesterol Level Testing, Diabetes Testing, HIV Testing, Pregnancy Testing and Others. Routine Testing dominated the Telehealth and Retail Lab Testing market in 2021. Routine Testing is necessary for assisting medical professionals with diagnoses of disease, confirmation of a medical condition, or preventive care. These tests are done on a regular basis and often have a fast turnaround.

U.S. Telehealth and Retail Lab Testing Market, By End-user

• Diagnostics Laboratory
• Hospital
• Speciality Labs
• Others

To Get a Summarized Market Report By End-User -

On the basis of End user, the U.S. Telehealth and Retail Lab Testing Market has been segmented into Diagnostics Laboratory, Hospital, Speciality Labs, and Others. Diagnostics Laboratory is expected to dominate the Telehealth and Retail Lab Testing market over the forecast period. Diagnostic tests are the center of several medical decisions. This reality became evident early in the pandemic. The telehealth sector has expanded access to primary care at a time when a patient’s capability to see a doctor is severely limited. Accordingly, providers growing to expand their portfolio to meet demand as the trend to change traditional health checks with virtual telehealth experiences surges.

U.S. Telehealth and Retail Lab Testing Market, Mode of Payment

• Insurance Pay
• Consumer Pay

Insurance Pay accounted for the largest market share of 88.09% in 2022, with a market value of USD 907.43 Million, and is projected to grow at the highest CAGR of 15.79% during the forecast period. Consumer Pay was the second-largest market in 2022, valued at USD 122.69 Million in 2022; it is projected to grow at a CAGR of 10.85%.

Key Players

The U.S. Telehealth and Retail Lab Testing Market is highly fragmented with the presence of a large number of players in the market. Some of the major companies include Laboratory Corporation of America, 23andMe, Any Lab Test Now, Color Health, Inc., DirectLabs, LLC., Everlywell, EasyDNA, MyMedLab, Medichecks.com Ltd., and Quest Diagnostics, GameChanger, and Cura.

Key Developments

• 23andME acquired Lemonaid Health and the acquisition will provides telemedicine platform to advance its vision of individualized primary care that empowers consumers to live healthier lives
• Labcorp signed agreements with Ascension, one of the nation’s top Catholic and non-profit health systems, to administer Ascension’s hospital-based laboratories in ten states and to buy certain assets from the health system’s outreach laboratory business.

Report Scope

To Get Customized Report Scope- 

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various pers